Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Bristol Myers Squibb Co. said it will spend $40 billion in the US over the next five years, joining a slew of drug companies ...

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

(Reuters) -Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in ...